Fritextsökning
Innehållstyper
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
De ska bli framtidens ledare i global hälsa
Åtta forskare har antagits som Sight fellows hos Swedish institute for global health transformation. De ska utvecklas till ledare i FN:s anda.
-
Stor kartläggning av svensk läkemedelsutveckling - "Väldigt imponerande bidrag"
Trots tuffa tider planerar två av tre life science-bolag att nyrekrytera – och antalet läkemedelsprojekt fortsätter att öka. Det visar branschorganisationen Swe...
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
GSK och Novartis i storaffär
Läkemedelsjättarna köper, säljer och bildar samriskbolag inom receptfria läkemedel.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Lovande för simeprevir
Medivir visar upp resultat från kliniska studier med sin hepatit C-behandling i olika kombinationer.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Google ger sig in i biotech-branschen
Sökmotorjättens nystartade bolag Calico ska fokusera på åldrande och åldersrelaterade sjukdomar.
-
I drömlandet Narnia funkar allt
Sverige kan bli ett Narnia. Elementen finns men vi behöver samverka för att nå målet
-
Klinisk studie av läkemedel mot apkoppor inleds i USA
Forskare i USA vill ta reda på hur väl det antivirala läkemedlet tekovirimat hjälper mot apkoppor. Nu inleds en fas III-studie.
-
Sales Representative, Applied Biosystems
-
Ebolabolag rusar efter FDA-beslut
Virusepedemins spridning i Västafrika banar väg för amerikanska Tekmira.
-
30 miljoner till malariaforskning
Oliver Billker, Umeå universitet, får 30 miljoner kronor under sex år för att studera genfunktion hos parasiter.
-
Första patienten i håravfallsstudie
Follicum har behandlat första patienten i sin fas II-studie.